2020 annual financial data
Alnylam Pharmaceuticals 2020 Net margin
Direct answer
Net margin was -174.15%.
Operating income was -828.44M USD and net income was -858.28M USD.
Operating cash flow was -614.96M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 492.85M USD
- Operating income
- -828.44M USD
- Net income
- -858.28M USD
- Operating cash flow
- -614.96M USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years